Semnur Pharmaceuticals, Inc. Adjustments to Additional Paid in Capital, Other
Semnur Pharmaceuticals, Inc. (SMNR) reported Adjustments to Additional Paid in Capital, Other of -$567.82 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2023-11-09.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2023-11-09
- Semnur Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2022-06-30 was -$567.82K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month |
|---|---|
| 2022-06-30 | -$567.82K 10-Q · filed 2023-11-09 |